Ziprasidone
- Product NDC
- 70518-3376
- 11-digit product format
- 705183376
- Labeler code
- 70518
- Product ID
- 70518-3376_f0d2ddca-ee8f-7a31-e053-2995a90a5faa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ziprasidone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA020825
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-03-02
- Marketing end
- 0000-00-00
- Substance
- ZIPRASIDONE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3376-0 | 70518337600 | 30 CAPSULE in 1 BLISTER PACK (70518-3376-0) | 30 capsule | 2022-03-02 | 0000-00-00 | No | No | Current |
| 70518-3376-1 | 70518337601 | 30 POUCH in 1 BOX (70518-3376-1) > 1 CAPSULE in 1 POUCH (70518-3376-2) | 30 pouch | 2022-12-27 | 0000-00-00 | No | No | Current |